Picture of Joyzyme logo

8622 Joyzyme News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Huakang Biomedical Holdings Is Expected To Record A Decrease In Revenue For Six Months

July 26 (Reuters) - Huakang Biomedical Holdings Co Ltd
 8622.HK :
    * GROUP IS EXPECTED TO RECORD A DECREASE IN REVENUE FOR SIX
MONTHS
ENDED 30 JUNE 2019
    * EXPECTED TO RECORD A DECREASE IN PROFIT BEFORE LISTING
EXPENSES
FOR SIX MONTHS ENDED 30 JUNE 2019
    * EXPECTED RESULT DUE TO DECREASE IN SALES TO SOME OF
CUSTOMERS OF
GROUP
    * EXPECTED RESULT DUE TO DECREASE IN SALES TO SOME OF
CUSTOMERS OF
GROUP, INCLUDING DIRECT SALES CUSTOMERS

Source text for Eikon:  urn:newsml:reuters.com:*:nHKS8j9073
Further company coverage:  8622.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Joyzyme

See all news